Patent · US Expired

Quinoline derivatives

US7064134B2 · kind B2 · utility

2Cited by

4References

20Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Michael G. Klug · Brooklyn Park, US
Patrizio Mattei · Riehen, CH
Werner Mueller · Cologne, DE
Werner Neidhart · Hagenthal-le-Bas, FR
Matthias Nettekoven · Weil am Rhein, DE
Philippe Pflieger · Schwoben, FR
Jean-Marc Plancher · Rixheim, FR

Key dates

Filing date	Nov 10, 2005
Grant date	Jun 20, 2006
Priority date	—
Expiry date	Nov 10, 2025

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula Ias well as pharmaceutically acceptable salts and esters thereof, wherein R1, R2, R3, A1 and A2 have the significance given in claim 1, can be used in the form of pharmaceutical preparations for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.